Literature DB >> 1381294

Decreased collagen gene expression and absence of fibrosis in thyroid hormone-induced myocardial hypertrophy. Response of cardiac fibroblasts to thyroid hormone in vitro.

J Yao1, M Eghbali.   

Abstract

The regulatory effects of thyroid hormone on biosynthesis of myocardial proteins that originate from cardiac myocytes are well established. Little is known, however, of regulatory effects of thyroid hormone on interstitial proteins. In this study we examined the effects of thyroid hormone on collagen gene expression in thyroid hormone-induced myocardial hypertrophy and the response of cardiac fibroblasts to thyroid hormone in culture. Adult male Sprague-Dawley rats were treated intraperitoneally with L-thyroxin (10 micrograms/100 g body wt) for 2 hours or 1, 2, 3, 6, 12, or 14 days. Northern blot analysis of RNA from total ventricular tissue showed that after 2 hours of treatment, the abundance of mRNA for pro alpha 2(I) collagen decreased by 53% (p less than 0.05) and reached the lowest level (60% decrease, p less than 0.02) at day 1, remained diminished at day 3, and then gradually returned toward normal levels. After transient transfection of chimeric DNA containing collagen type I promoter-chloramphenicol acetyl transferase (CAT) gene into the thyroxin-treated cardiac fibroblasts, the level of CAT activity decreased significantly. Treatment of cardiac fibroblasts in culture (10 nM L-thyroxin) resulted in a 33% (p less than 0.005) decrease in the abundance of mRNA for pro alpha 2(I) collagen. The stability of the mRNA for pro alpha 2(I) collagen in cardiac fibroblasts, as measured by mRNA half-life, was slightly (16.6%) decreased by thyroid-hormone treatment. Collagen synthesis as shown by immunofluorescent staining of intracellular collagen in cultured fibroblasts and in frozen sections of myocardium was also diminished.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1381294     DOI: 10.1161/01.res.71.4.831

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  31 in total

1.  Thyroid hormone improves function and Ca2+ handling in pressure overload hypertrophy. Association with increased sarcoplasmic reticulum Ca2+-ATPase and alpha-myosin heavy chain in rat hearts.

Authors:  K C Chang; V M Figueredo; J H Schreur; K Kariya; M W Weiner; P C Simpson; S A Camacho
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

2.  Thyroid hormones increase collagen I and cartilage oligomeric matrix protein (COMP) expression in vitro human tenocytes.

Authors:  Anna C Berardi; Francesco Oliva; Martina Berardocco; Marina la Rovere; Patrizia Accorsi; Nicola Maffulli
Journal:  Muscles Ligaments Tendons J       Date:  2014-11-17

Review 3.  Role of thyroid hormones in ventricular remodeling.

Authors:  Viswanathan Rajagopalan; A Martin Gerdes
Journal:  Curr Heart Fail Rep       Date:  2015-04

4.  Hyperresponsiveness of vitamin D receptor gene expression to 1,25-dihydroxyvitamin D3. A new characteristic of genetic hypercalciuric stone-forming rats.

Authors:  J Yao; P Kathpalia; D A Bushinsky; M J Favus
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

Review 5.  Signaling mechanisms in thyroid hormone-induced cardiac hypertrophy.

Authors:  Kaie Ojamaa
Journal:  Vascul Pharmacol       Date:  2009-12-11       Impact factor: 5.773

6.  Hyperthyroidism increases adenosine transport and metabolism in the rat heart.

Authors:  R T Smolenski; M H Yacoub; A M Seymour
Journal:  Mol Cell Biochem       Date:  1995-02-23       Impact factor: 3.396

7.  The expression of mRNA of cytokines and of extracellular matrix proteins in triiodothyronine-treated rat hearts.

Authors:  Barbara Ziegelhöffer-Mihalovicová; Wilfried Briest; Hideo A Baba; Beate Rassler; Heinz-Gerd Zimmer
Journal:  Mol Cell Biochem       Date:  2003-05       Impact factor: 3.396

8.  Myocardial ultrasonic tissue characterization in patients with thyroid dysfunction.

Authors:  Minna M D Romano; Léa M Z Maciel; Oswaldo C Almeida-Filho; Antonio Pazin-Filho; André Schmidt; Benedito C Maciel
Journal:  Cardiovasc Ultrasound       Date:  2010-04-23       Impact factor: 2.062

Review 9.  Thyroid functional disease: an under-recognized cardiovascular risk factor in kidney disease patients.

Authors:  Connie M Rhee; Gregory A Brent; Csaba P Kovesdy; Offie P Soldin; Danh Nguyen; Matthew J Budoff; Steven M Brunelli; Kamyar Kalantar-Zadeh
Journal:  Nephrol Dial Transplant       Date:  2014-02-25       Impact factor: 5.992

10.  Low-dose T₃ replacement restores depressed cardiac T₃ levels, preserves coronary microvasculature and attenuates cardiac dysfunction in experimental diabetes mellitus.

Authors:  Nathan Y Weltman; Kaie Ojamaa; Evelyn H Schlenker; Yue-Feng Chen; Riccardo Zucchi; Alessandro Saba; Daria Colligiani; Viswanathan Rajagopalan; Christine J Pol; A Martin Gerdes
Journal:  Mol Med       Date:  2014-05-01       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.